Teva Pharmaceuticals (TEVA) Consolidates On Wednesday's Gains
By Mark Moneymaster
March 18, 2010 11:10 AM
March 18, 2010 11:10 AM
Symbols: TEVA
Teva Pharmaceutical Industries (NASDAQ: TEVA) was among the large-cap drug stocks to gain in morning trading on Thursday, gaining on news that it plans to buy German generic drug-maker Ratiopharm Group International for $5 billion. Teva Pharmaceutical Industries (TEVA) gained 3.23% to $61.86 on Thursday morning.
Teva Pharmaceutical Industries (TEVA), which had breached above its 20 day MA in the closing hour of trading on Wednesday, built up on those gains after a gap-up opening on Thursday morning. Teva Pharmaceutical Industries (TEVA) is the top producer in the world of the generic pharmaceuticals.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
